Pugsley TA[au] - Search Results

Year	Number of Results
1968	2
1970	2
1974	2
1975	1
1976	6
1977	4
1978	2
1979	4
1981	1
1983	2
1985	2
1986	6
1987	1
1988	5
1989	3
1990	4
1991	3
1992	2
1993	3
1994	3
1995	6
1996	4
1997	8
1998	4
1999	2
2000	5
2001	1
2002	3
2006	1
2022	0

1

Pyrazolo[1,5-a]pyrimidine CRF-1 receptor antagonists.

Wustrow DJ, Capiris T, Rubin R, Knobelsdorf JA, Akunne H, Davis MD, MacKenzie R, Pugsley TA, Zoski KT, Heffner TG, Wise LD. Wustrow DJ, et al. Among authors: pugsley ta. Bioorg Med Chem Lett. 1998 Aug 18;8(16):2067-70. doi: 10.1016/s0960-894x(98)00372-2. Bioorg Med Chem Lett. 1998. PMID: 9873487

2

3-arylimino-2-indolones are potent and selective galanin GAL3 receptor antagonists.

Konkel MJ, Lagu B, Boteju LW, Jimenez H, Noble S, Walker MW, Chandrasena G, Blackburn TP, Nikam SS, Wright JL, Kornberg BE, Gregory T, Pugsley TA, Akunne H, Zoski K, Wise LD. Konkel MJ, et al. Among authors: pugsley ta. J Med Chem. 2006 Jun 29;49(13):3757-8. doi: 10.1021/jm060001n. J Med Chem. 2006. PMID: 16789730

3

Synthesis and potential antipsychotic activity of 1H-imidazo[1,2-c]pyrazolo[3,4-e]pyrimidines.

DeWald HA, Beeson NW, Hershenson FM, Wise LD, Downs DA, Heffner TG, Coughenour LL, Pugsley TA. DeWald HA, et al. Among authors: pugsley ta. J Med Chem. 1988 Feb;31(2):454-61. doi: 10.1021/jm00397a032. J Med Chem. 1988. PMID: 2892936

4

1,3-Dialkyl-4-(iminoarylmethyl)-1H-pyrazol-5-ols. A series of novel potential antipsychotic agents.

Wise LD, Butler DE, DeWald HA, Lustgarten DM, Pattison IC, Schweiss DN, Coughenour LL, Downs DA, Heffner TG, Pugsley TA. Wise LD, et al. Among authors: pugsley ta. J Med Chem. 1987 Oct;30(10):1807-12. doi: 10.1021/jm00393a021. J Med Chem. 1987. PMID: 2888897

5

Dopamine autoreceptor agonists as potential antipsychotics. 2. (Aminoalkoxy)-4H-1-benzopyran-4-ones.

Jaen JC, Wise LD, Heffner TG, Pugsley TA, Meltzer LT. Jaen JC, et al. Among authors: pugsley ta. J Med Chem. 1991 Jan;34(1):248-56. doi: 10.1021/jm00105a039. J Med Chem. 1991. PMID: 1671416

6

Functional activity of new C-terminal cyclic-neurotensin fragment analogs.

Akunne HC, Darling S, Zoski K, Sefler AM, He JX, Sawyer TK, Pugsley TA, Cody WL. Akunne HC, et al. Among authors: pugsley ta. Neuropeptides. 1996 Jun;30(3):213-8. doi: 10.1016/s0143-4179(96)90066-9. Neuropeptides. 1996. PMID: 8819144

7

Isoindolinone enantiomers having affinity for the dopamine D4 receptor.

Belliotti TR, Brink WA, Kesten SR, Rubin JR, Wustrow DJ, Zoski KT, Whetzel SZ, Corbin AE, Pugsley TA, Heffner TG, Wise LD. Belliotti TR, et al. Among authors: pugsley ta. Bioorg Med Chem Lett. 1998 Jun 16;8(12):1499-502. doi: 10.1016/s0960-894x(98)00252-2. Bioorg Med Chem Lett. 1998. PMID: 9873377

8

Effects of benzoctamine and chlordiazepoxide on turnover and uptake of 5-hydroxytryptamine in the brain.

Lippmann W, Pugsley TA. Lippmann W, et al. Among authors: pugsley ta. Br J Pharmacol. 1974 Aug;51(4):571-5. doi: 10.1111/j.1476-5381.1974.tb09676.x. Br J Pharmacol. 1974. PMID: 4480288 Free PMC article.

9

Studies on the interrelationship between the syntheses of noradrenaline and metaraminol.

Johnson GE, Pugsley TA. Johnson GE, et al. Among authors: pugsley ta. Br J Pharmacol. 1970 May;39(1):167-74. doi: 10.1111/j.1476-5381.1970.tb09566.x. Br J Pharmacol. 1970. PMID: 4317857 Free PMC article.

10

A new type of prodrug of catecholamines: an opportunity to improve the treatment of Parkinson's disease.

Venhuis BJ, Rodenhuis N, Wikström HV, Wustrow D, Meltzer LT, Wise LD, Johnson SJ, Pugsley TA, Sundell S, Dijkstra D. Venhuis BJ, et al. Among authors: pugsley ta. J Med Chem. 2002 Jun 6;45(12):2349-51. doi: 10.1021/jm025508m. J Med Chem. 2002. PMID: 12036342

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results